Recombinant multi-species TAFA4/FAM19A4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TAFA4/FAM19A4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is a member of the TAFA family which is composed of five highly homologous genes that encode small secreted proteins. These proteins contain conserved cysteine residues at fixed positions, and are distantly related to MIP-1alpha, a member of the CC-chemokine family. The TAFA proteins are predominantly expressed in specific regions of the brain, and are postulated to function as brain-specific chemokines or neurokines, that act as regulators of immune and nervous cells. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Nov 2011]
The Alternative Names of target: C130034I18Rik,Chemokine-like protein TAFA-4,FAM19A4,Fam19a4,Fam19a4 Tafa-4,TAFA-4,TAFA4,Tafa-4,Tafa4

Target products collectionGo to TAFA4/FAM19A4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0196-Ag-1/ GM-Tg-hg-SE0196-Ag-2 Human TAFA4/FAM19A4 protein Human
GM-Tg-rg-SE0196-Ag-1/ GM-Tg-rg-SE0196-Ag-2 Rat TAFA4/FAM19A4 protein Rat
GM-Tg-mg-SE0196-Ag-1/ GM-Tg-mg-SE0196-Ag-2 Mouse TAFA4/FAM19A4 protein Mouse
GM-Tg-cynog-SE0196-Ag-1/ GM-Tg-cynog-SE0196-Ag-2 Cynomolgus/Rhesus macaque TAFA4/FAM19A4 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0196-Ag-1/ GM-Tg-felg-SE0196-Ag-2 Feline TAFA4/FAM19A4 protein Feline
GM-Tg-cang-SE0196-Ag-1/ GM-Tg-cang-SE0196-Ag-2 Canine TAFA4/FAM19A4 protein Canine
GM-Tg-bovg-SE0196-Ag-1/ GM-Tg-bovg-SE0196-Ag-2 Bovine TAFA4/FAM19A4 protein Bovine
GM-Tg-equg-SE0196-Ag-1/ GM-Tg-equg-SE0196-Ag-2 Equine TAFA4/FAM19A4 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0196-Ag-1/ GM-Tg-hg-SE0196-Ag-2; GM-Tg-rg-SE0196-Ag-1/ GM-Tg-rg-SE0196-Ag-2;
GM-Tg-mg-SE0196-Ag-1/ GM-Tg-mg-SE0196-Ag-2; GM-Tg-cynog-SE0196-Ag-1/ GM-Tg-cynog-SE0196-Ag-2;
GM-Tg-felg-SE0196-Ag-1/ GM-Tg-felg-SE0196-Ag-2; GM-Tg-cang-SE0196-Ag-1/ GM-Tg-cang-SE0196-Ag-2;
GM-Tg-bovg-SE0196-Ag-1/ GM-Tg-bovg-SE0196-Ag-2; GM-Tg-equg-SE0196-Ag-1/ GM-Tg-equg-SE0196-Ag-2
Products Name TAFA4/FAM19A4 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name TAFA4/FAM19A4
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TAFA4/FAM19A4 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.